Cronos Group Inc. (NASDAQ:CRON - Free Report) - Research analysts at Roth Capital cut their Q2 2025 earnings estimates for Cronos Group in a note issued to investors on Wednesday, November 13th. Roth Capital analyst W. Kirk now forecasts that the company will post earnings of $0.00 per share for the quarter, down from their prior estimate of $0.01. The consensus estimate for Cronos Group's current full-year earnings is ($0.05) per share. Roth Capital also issued estimates for Cronos Group's FY2025 earnings at $0.00 EPS.
Cronos Group Stock Performance
CRON traded down $0.10 during mid-day trading on Thursday, reaching $2.07. The stock had a trading volume of 987,255 shares, compared to its average volume of 1,935,569. The stock has a market capitalization of $791.35 million, a P/E ratio of -16.31 and a beta of 0.98. Cronos Group has a 52 week low of $1.85 and a 52 week high of $3.14. The firm's fifty day simple moving average is $2.17 and its two-hundred day simple moving average is $2.35.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in CRON. Mackenzie Financial Corp bought a new position in shares of Cronos Group in the second quarter valued at $3,237,000. Concurrent Investment Advisors LLC acquired a new position in shares of Cronos Group during the 1st quarter worth about $79,000. Virtu Financial LLC lifted its stake in Cronos Group by 34.9% in the 1st quarter. Virtu Financial LLC now owns 105,985 shares of the company's stock valued at $277,000 after purchasing an additional 27,446 shares during the last quarter. Janney Montgomery Scott LLC grew its holdings in Cronos Group by 50.4% during the first quarter. Janney Montgomery Scott LLC now owns 304,063 shares of the company's stock worth $794,000 after purchasing an additional 101,903 shares during the period. Finally, National Bank of Canada FI increased its position in Cronos Group by 1,094.4% during the second quarter. National Bank of Canada FI now owns 15,169 shares of the company's stock worth $35,000 after buying an additional 13,899 shares during the last quarter. Institutional investors and hedge funds own 8.71% of the company's stock.
About Cronos Group
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
See Also
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
